81.31

0.48% -0.39

After Hours: 81.31

Solventum Corp (SOLV)

Overview News Price History Discussions Forecast

Solventum Corp stock is traded at $81.31, with a volume of 1.12M. It is down -0.48% in the last 24 hours and up +9.05% over the past month. Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.

Previous Close:

$81.70

Open:

$81.26

24h Volume:

1.12M

Relative Volume:

0.68

Market Cap:

$14.08B

Revenue:

$8.28B

Net Income/Loss:

$1.43B

P/E Ratio:

9.9593

EPS:

8.1642

Net Cash Flow:

$-203.00M

1W Performance:

+6.01%

1M Performance:

+9.05%

6M Performance:

+2.30%

1Y Performance:

+10.09%

1-Day Range:

$80.63

$83.34

1-Week Range:

$75.55

$83.34

52-Week Range:

$62.38

$88.20

Solventum Corp Stock (SOLV) Company Profile

Name

Solventum Corp

Sector

Healthcare (1092)

Industry

Medical Instruments & Supplies (57)

Phone

651-733-1110

Address

1750 YANKEE DOODLE ROAD, EAGAN

Employee

20,000

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

SOLV's Discussions on Twitter

Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SOLV Solventum Corp	81.31	14.15B	8.28B	1.43B	-203.00M	8.1642
ISRG Intuitive Surgical Inc	345.42	142.49B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	158.17	44.07B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	70.26	34.44B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	39.79	34.76B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	198.99	29.41B	5.54B	1.52B	1.74B	10.37

Solventum Corp Stock (SOLV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-24-26	Initiated	Rothschild & Co Redburn	Sell
Jan-26-26	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Jan-20-26	Upgrade	Mizuho	Neutral → Outperform
Dec-02-25	Upgrade	BTIG Research	Neutral → Buy
Oct-01-25	Initiated	UBS	Neutral
Sep-11-25	Initiated	Jefferies	Hold
Jul-15-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jul-01-25	Upgrade	Argus	Hold → Buy
Jun-06-25	Initiated	KeyBanc Capital Markets	Sector Weight
May-19-25	Upgrade	Piper Sandler	Neutral → Overweight
Dec-04-24	Initiated	Mizuho	Neutral
Oct-08-24	Initiated	Stifel	Buy
Oct-07-24	Initiated	Piper Sandler	Neutral
Sep-26-24	Initiated	Wolfe Research	Peer Perform
Sep-05-24	Initiated	BTIG Research	Neutral
Jun-24-24	Initiated	Argus	Hold
May-30-24	Initiated	Goldman	Sell
May-10-24	Initiated	BofA Securities	Neutral
Apr-10-24	Initiated	Morgan Stanley	Equal-Weight
Apr-08-24	Initiated	Wells Fargo	Equal Weight
Apr-02-24	Initiated	Edward Jones	Hold

View All

Solventum Corp Stock (SOLV) Latest News

Jul 18, 2026

Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026 - BioSpace

Jul 16, 2026

Jul 15, 2026

Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune

Jul 15, 2026

Solventum to report Q2 FY26 earnings on August 5, 2026 - scanx.trade

Jul 15, 2026

Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch

Jul 15, 2026

Jul 14, 2026

Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch

Jul 14, 2026

SOLN5957967 Bond Profile — Key Metrics - TradingView

Jul 14, 2026

SOLN5759820 Bond Profile — Key Metrics - TradingView

Jul 14, 2026

Jul 13, 2026

BTIG Adjusts Solventum Price Target to $91 From $89, Maintains Buy Rating - marketscreener.com

Jul 13, 2026

Solventum Corporation (SOLV) Stock Analysis: Evaluating a 7% Potential Upside Amidst Sector Challenges - DirectorsTalk Interviews

Jul 13, 2026

Jul 10, 2026

Solving A Lackluster Growth Outlook Should Be Solventum’s Next Priority (NYSE:SOLV) - Seeking Alpha

Jul 10, 2026

Solventum (SOLV) Insider Trading Activity 2026 $SOLV - MarketBeat

Jul 10, 2026

Jul 09, 2026

The Bull Case For Solventum (SOLV) Could Change Following Dual Russell 2500 Index Inclusion - simplywall.st

Jul 09, 2026

Jul 08, 2026

Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch

Jul 08, 2026

Jul 06, 2026

Solventum Foundation and America’s ToothFairy Join Forces - Dentistry Today

Jul 06, 2026

Solventum Corporation (SOLV) Stock Analysis: Exploring a 4.96% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Jul 06, 2026

Jul 01, 2026

Solventum (SOLV) Joins Russell Indices, Is Its 6% Undervalued View Still Compelling? - simplywall.st

Jul 01, 2026

Jun 30, 2026

solventum-logo-horz-clr-rev-rgb - Dentistry UK

Jun 30, 2026

Solventum (SOLV) Is Up 6.4% After Russell 2500 Value Inclusion Shifted Its Healthcare Role - simplywall.st

Jun 30, 2026

Jun 29, 2026

Solventum stock: Is SOLV underperforming the healthcare sector? - MSN

Jun 29, 2026

Solventum Corp. stock falls Monday, underperforms market - MarketWatch

Jun 29, 2026

Jun 28, 2026

Solventum Corporation(NYSE: SOLV) added to Russell 2500 Index - marketscreener.com

Jun 28, 2026

Jun 27, 2026